книги2 / 325

Литература

1.International society for the study of vulvovaginal disease recommendations for the diagnosis and treatment of vaginitis / Eds. P. Vieira-Baptista, C.K. Stockdale, J. Sobel. — Lisbon: Admedic, 2023. — 198 p.

2.Радзинский В.Е., Савичева А.М., Воробьёв С.В. и др. Биоценоз влагалища. Норма. Нарушения. Восстановление / Под ред. В.Е. Радзинского, А.М. Савичевой. — М.: Редакция журнала StatusPraesens, 2023. — 360 с.

3.Rao V.L., Mahmood T. Vaginal discharge // Obstet. Gynaecol. Reprod. Med. — 2020. — Vol. 30. — №1. — P. 11–18.

4.Sim M., Logan S., Goh L.H. Vaginal discharge: evaluation and management in primary care // Singapore Med. J. — 2020. — Vol. 61. — №6. — P. 297–301. [PMID: 32754764]

5.Holdcroft A.M., Ireland D.J., Payne M.S. The vaginal microbiome in health and disease — what role do common intimate hygiene practices play? // Microorganisms. — 2023. — Vol. 11. — №2. — P. 298. [PMID: 36838262]

6.Song S.D., Acharya K.D., Zhu J.E. et al. Daily vaginal microbiota fluctuations associated with natural hormonal cycle, contraceptives, diet, and exercise // MSphere. — 2020. — Vol. 5. — №4. [PMID: 32641429]

7.Verstraelen H., Vieira-Baptista P., De Seta F. et al. I. Research development, lexicon, defining «normal» and the dynamics throughout women’s lives / The vaginal microbiome // J. Low. Genit. Tract Dis. — 2022. — Vol. 26. — №1. — P. 73–78. [PMID: 34928256]

8.Lev-Sagie A., De Seta F., Verstraelen H. et al. II. Vaginal dysbiotic conditions / The vaginal microbiome // J. Low. Genit. Tract Dis. — 2022. — Vol. 26. — №1. — P. 79–84. [PMID: 34928257]

9.Amsel R., Totten P.A., Spiegel C.A. et al. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations // Am. J. Med. — 1983. — Vol. 74. — №1. — P. 14–22. [PMID: 6600371]

10.Nugent R.P., Krohn M.A., Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation // J. Clin. Microbiol. — 1991. — Vol. 29. — №2. — P. 297–301. [PMID: 1706728]

11.Challa A., Sood S., Kachhawa G. et al. Diagnostic concordance between Amsel’s criteria and the Nugent scoring method in the assessment of bacterial vaginosis // Sex. Health. — 2022. — Vol. 18. — №6. — P. 512–514. [PMID: 34914580]

12.Dean G., Soni S., Pitt R. et al. Treatment of mild-to-mod- erate pelvic inflammatory disease with a short-course azith- romycin-based regimen versus ofloxacin plus metronidazole: Results of a multicentre, randomised controlled trial // Sex. Transm. Infect. — 2021. — Vol. 97. — №3. — P. 177–182. [PMID: 33188138]

13.Sherrard J., Wilson J., Donders G. et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge // Int. J. STD AIDS. — 2018. — Vol. 29. — №13. — P. 1258–1272. [PMID: 30049258]

14.Регистрационное удостоверение препарата «Флуомизин». — ГРЛС, 2020. — URL: https://grls.rosminzdrav. ru/Grls_View_v2.aspx?routingGuid=4ee550e7-51bb-44fc- 993b-4a6b8dce7ad0&t=.

15.Bailly C. Medicinal applications and molecular targets of dequalinium chloride // Biochem. Pharmacol. — 2021. — Vol. 186. — P. 114467. [PMID: 33577890]

16.Donders G., Bellen G., Donders F. et al. Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials // Eur. J. Clin. Microbiol. Infect. Dis. — 2017. — Vol. 36. — №4. — P. 731–738. [PMID: 27933401]

17.Mendling W., Weissenbacher E.R., Gerber S. et al. Use of locally delivered dequalinium chloride in the treatment of vagi-

nal infections: A review // Arch. Gynecol. Obstet. — 2016. — Vol. 293. — №3. — P. 469–484. [PMID: 26506926]

18.Liu H.F., Yi N. A systematic review and meta-analysis on the efficacy of probiotics for bacterial vaginosis // Eur. Rev. Med. Pharmacol. Sci. — 2022. — Vol. 26. — №1. — P. 90–98. [PMID: 35049024]

19.Vieira-Baptista P., Lima-Silva J., Preti M. et al. Vaginal leptothrix: An innocent bystander? // Microorganisms. — 2022. — Vol. 10. — №8. — P. 1645. [PMID: 36014063]

20.Miller E.A., Beasley D.E., Dunn R.R., Archie E.A. Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique? // Front. Microbiol. — 2016. — Vol. 7. — P. 1936. [PMID: 28008325]

21.Ventolini G., Vieira-Baptista P., De Seta F. et al. IV. The role of vaginal microbiome in reproduction and in gynecologic cancers / The vaginal microbiome // J. Low. Genit. Tract Dis. — 2022. — Vol. 26. — №1. — P. 93–98. [PMID: 34928259]

22.Juliana N.C.A., Suiters M.J.M., Al-Nasiry S. et al. The association between vaginal microbiota dysbiosis, bacterial vaginosis, and aerobic vaginitis, and adverse pregnancy outcomes of women living in sub-Saharan Africa: A systematic review // Front. Public Health. — 2020. — Vol. 8. — P. 567885. [PMID: 33363078]

23.Kahwati L.C., Clark R., Berkman N. et al. Screening for bacterial vaginosis in pregnant adolescents and women to prevent preterm delivery: Updated evidence report and systematic review for the us preventive services task force // JAMA. — 2020. — Vol. 323. — №13. — P. 1293–1309. [PMID: 32259235]

24.Gaspar C., Rolo J., Cerca N. et al. Dequalinium chloride effectively disrupts bacterial vaginosis (BV) Gardnerella spp. biofilms // Pathogens. — 2021. — Vol. 10. — №3. — P. 261. [PMID: 33668706]

25.Sobel J.D., Faro S., Force R.W. et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations // Am. J. Obstet. Gynecol. — 1998. — Vol. 178. — №2. — P. 203–211. [PMID: 9500475]

26.Workowski K.A., Bachmann L.H., Chan P.A. et al. Sexually transmitted infections treatment guidelines, 2021 // MMWR Recomm. Rep. — 2021. — Vol. 70. — №4. — P. 1–187. [PMID: 34292926]

27.Sobel J.D. Vulvovaginal candidosis // Lancet. — 2007. — Vol. 369. — №9577. — P. 1961–1971. [PMID: 17560449]

28.Schwebke J.R., Gaydos C.A., Nyirjesy P. et al. Diagnostic performance of a molecular test versus clinician assessment of vaginitis // J. Clin. Microbiol. — 2018. — Vol. 56. — №6. [PMID: 29643195]

29.Vieira-Baptista P., Silva A.R., Costa M. et al. Clinical validation of a new molecular test (Seegene Allplex™ vaginitis) for the diagnosis of vaginitis: A cross-sectional study // BJOG. — 2021. — Vol. 128. — №8. — P. 1344–1352. [PMID: 33540484]

30.Genovese C., Cianci A., Corsello S. et al. Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis // Minerva Ginecol. — 2019. — Vol. 71. — №4. — P. 321–328. [PMID: 31106557]

31.Denison H.J., Worswick J., Bond C.M. et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush) // Cochrane Database Syst. Rev. — 2020. — Vol. 8. — Art. №CD002845. [PMID: 32845024]

32.Sobel J.D., Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species // Expert Opin. Pharmacother. — 2018. — Vol. 19. — №9. — P. 971–977. [PMID: 29932786]

33.Thamkhantho M., Chayachinda C. Vaginal tablets of dequalinium chloride 10 mg versus clotrimazole 100 mg for vaginal candidiasis: A double-blind, randomized study // Arch. Gy-

necol. Obstet. — 2021. — Vol. 303. — №1. — P. 151–160. [PMID: 32940765]

34.Kissinger P.J., Gaydos C.A., Sena A.C. et al. Diagnosis and management of trichomonas vaginalis: Summary of evidence reviewed for the 2021 Centers for disease control and prevention sexually transmitted infections treatment guidelines // Clin. Infect. Dis. — 2022. — Vol. 74. — Suppl. 2. — P. S152– S161. [PMID: 35416973]

35.Hobbs M.M., Sena A.C. Modern diagnosis of Trichomonas vaginalis infection // Sex. Transm. Infect. — 2013. — Vol. 89. — №6. — P. 434–438. [PMID: 23633669]

36.Gaydos C.A., Hobbs M., Marrazzo J. et al. Rapid diagnosis of trichomonas vaginalis by testing vaginal swabs in an isothermal helicase-dependent AmpliVue assay // Sex. Transm. Dis. — 2016. — Vol. 43. — №6. — P. 369–373. [PMID: 27196258]

37.Gaydos C.A., Schwebke J., Dombrowski J. et al. Clinical performance of the Solana(R) point-of-care trichomonas assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women // Expert Rev. Mol. Diagn. — 2017. — Vol. 17. — №3. — P. 303–306. [PMID: 28092466]

38.Kissinger P., Mena L., Levison J. et al. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women // J. Acquir. Immune Defic. Syndr. — 2010. — Vol. 55. — №5. — P. 565–571. [PMID: 21423852]

39.Kissinger P., Muzny C.A., Mena L.A. et al. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: An open-label, randomised controlled trial // Lancet Infect. Dis. — 2018. — Vol. 18. — №11. — P. 1251– 1259. [PMID: 30297322]

40.Legendre D., Muzny C.A., Kissinger P. Pharmacokinetic and pharmacodynamic effects of metronidazole may account for the superior efficacy of multidose therapy among women with trichomoniasis // Sex. Transm. Dis. — 2019. — Vol. 46. — №11. — P. 751–752. [PMID: 31644503]

41.Geng N., Wu W., Fan A. et al. Analysis of the risk factors for aerobic vaginitis: A case-control study // Gynecol. Obstet. Invest. — 2015. [Online ahead of print] [PMID: 26068172]

42.Vempati Y.S., Sobel J.D. Desquamative inflammatory vaginitis as an expression of systemic lupus erythematosus // J. Low. Genit. Tract Dis. — 2022. — Vol. 26. — №4. — P. 345–

346.[PMID: 35795900]

43.Yockey L., Dowst S., Zonozi R. et al. Inflammatory vaginitis in women on long-term rituximab treatment for autoimmune disorders // BMC Womens Health. — 2021. — Vol. 21. — №1. — P. 285. [PMID: 34353326]

44.Donders G.G.G., Bellen G., Grinceviciene S. et al. Aerobic vaginitis: no longer a stranger // Res. Microbiol. — 2017. — Vol. 168. — №9–10. — P. 845–858. [PMID: 28502874]

45.Reichman O., Sobel J. Desquamative inflammatory vaginitis // Best Pract. Res. Clin. Obstet. Gynaecol. — 2014. — Vol. 28. — №7. — P. 1042–1050. [PMID: 25132275]

46.Donders G., Greenhouse P., Donders F. et al. Genital tract GAS infection ISIDOG guidelines // J. Clin. Med. — 2021. — Vol. 10. — №9. — P. 2043. [PMID: 34068785]

47.Paavonen J., Brunham R.C. Bacterial vaginosis and desquamative inflammatory vaginitis // N. Engl. J. Med. — 2018. — Vol. 379. — №23. — P. 2246–2254. [PMID: 30575452]

48.Ma X., Wu M., Wang C. et al. The pathogenesis of prevalent aerobic bacteria in aerobic vaginitis and adverse pregnancy outcomes: A narrative review // Reprod. Health. — 2022. — Vol. 19. — №1. — P. 21. [PMID: 35090514]

49.Yang S., Zhang Y., Liu Y. et al. Clinical significance and characteristic clinical differences of cytolytic vaginosis in recurrent vulvovaginitis // Gynecol. Obstet. Invest. — 2017. — Vol. 82. — №2. — P. 137–143. [PMID: 27300413]

50.Varma K., Kansal M. Cytolytic vaginosis: A brief review // Journal of skin and sexually transmitted diseases. — 2022. — Vol. 4. — №2. — P. 206–210.

51.Pérez-López F.R., Vieira-Baptista P., Phillips N. et al. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy // Gynecol. Endocrinol. — 2021. — Vol. 37. — №8. — P. 740–745. [PMID: 34036849]

52.Vieira-Baptista P., Grincevičienė Š., Oliveira C. et al. How to perform, applica-tions, and interpretation: The International society for the study of vulvovaginal disease vaginal wet mount microscopy guidelines // J. Low. Genit. Tract Dis. — 2021. — Vol. 25. — №2. — P. 172–180. [PMID: 33631782]

53.Edwards D., Panay N. Treating vulvovaginal atrophy/ genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? // Climacteric. — 2016. — Vol. 19. — №2. — P. 151–161. [PMID: 26707589]

54.Kamilos M.F., Borrelli C.L. New therapeutic option in genitourinary syndrome of menopause: Pilot study using microablative fractional radiofrequency // Einstein (Sao Paulo). — 2017. — Vol. 15. — №4. — P. 445–451. [PMID: 29364367]

55.Paladine H.L., Desai U.A. Vaginitis: diagnosis and treatment // Am. Fam. Physician. — 2018. — Vol. 97. — №5. — P. 321–329. [PMID: 29671516]

56.Cunha A.R., Machado R.M., Palmeira-de-Oliveira A. et al. Characterization of commercially available vaginal lubricants: a safety perspective // Pharmaceutics. — 2014. — Vol. 6. — №3. — P. 530–542. [PMID: 25247884]

57.Rees M., Pérez-López F.R., Ceasu I. et al. Low-dose vaginal estrogens for postmenopausal vaginal atrophy: EMAS clinical guide // Maturitas. — 2012. — Vol. 73. — №2. — P. 171–

174.[PMID: 22818886]

58.Инструкция по медицинскому применению лекарственного препарата «Гинофлор Э». — ГРЛС, 2021. — URL: https://grls.minzdrav.gov.ru/Grls_View_v2.aspx?routing- Guid=0b063917-7f3e-479c-997e-757785d75e38.

59.Mueck A.O., Ruan X., Prasauskas V. et al. Treatment of

vaginal atrophy with estriol and lactobacilli combination: A clinical review // Climacteric. — 2018. — Vol. 21. — №2. — Р. 140–147. [PMID: 29381086]

60.The use of vaginal estrogen in women with a history of es- trogen-dependent breast cancer / ACOG Committee opinion №659 // Obstet. Gynecol. — 2016. — Vol. 127. — №3. — P. e93–e96. [PMID: 26901334]

61.Donders G., Bellen G., Neven P. et al. Effect of ultra-low- dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors // Eur. J. Clin. Microbiol. Infect. Dis. — 2015. — Vol. 34. — №10. — Р. 2023–2028. [PMID: 26223323]

62.Buchholz S., Mögele M., Lintermans A. et al. Vaginal estriol-lactobacilli combination and quality of life in endo- crine-treated breast cancer // Climacteric. — 2015. — Vol. 18. — №2. — Р. 252–259. [PMID: 25427450]

63.Moegele M., Buchholz S., Seitz S. et al. Vaginal estrogen therapy for patients with breast cancer // Geburtshilfe Frauenheilkd. — 2013. — Vol. 73. — №10. — Р. 1017–1022. [PMID: 24771890]

64.Mercier J., Morin M., Zaki D. et al. Pelvic floor muscle training as a treatment for genitourinary syndrome of menopause: A single-arm feasibility study // Maturitas. — 2019. — Vol. 125. — P. 57–62. [PMID: 31133219]

65.Capobianco G., Wenger J.M., Meloni G.B. et al. Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women // Arch. Gynecol. Obstet. — 2014. — Vol. 289. — №3. — P. 601–608. [PMID: 24057079]